Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 5/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.39 |
| ▸ | SLC5A1 | P13866 | 5/20 | 0.35 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.35 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12659725 | 0.93 | PPARG (0.40) | TYRTRPV1SLC28A3HSD17B10PPARG | |
| Alnuside B SCHEMBL22796510 | 0.77 | PPARG (0.49) | TYRSLC5A1SLC28A3HPGDHSD17B10 | |
| Alnuside B SCHEMBL12672476 | 0.77 | PPARG (0.49) | TYRSLC5A1SLC28A3HPGDHSD17B10 | |
| SCHEMBL31067732 | 0.74 | TYR (0.48) | TYRSLC5A1SLC5A2SLC28A3PPARG | |
| Oregonin SCHEMBL12659728 | 0.72 | PPARG (0.46) | TYRTRPV1PPARGPPARDPPARA | |
| Oregonin SCHEMBL29389089 | 0.72 | PPARG (0.46) | TYRTRPV1PPARGPPARDPPARA | |
| SCHEMBL15821766 | 0.70 | SLC5A1 (0.39) | TRPV1SLC5A1SLC5A2SLC28A3HPGD | |
| SCHEMBL15821769 | 0.70 | SLC5A1 (0.39) | TRPV1SLC5A1SLC5A2SLC28A3HPGD | |
| SCHEMBL1882706 | 0.70 | TRPV1 (0.40) | TRPV1SLC5A1SLC5A2SLC28A3HPGD | |
| SCHEMBL22795998 | 0.67 | TYR (0.39) | TYRTRPV1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110105738-A1 | DIARYL HEPATONOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS | RNL BIO CO., LTD. (KR) | 2011-05-05 | — | — | US | disclosed |
| US-20110105738-A1 | DIARYL HEPATONOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS | RNL BIO CO., LTD. (KR) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105738-A1 | DIARYL HEPATONOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS | HAVCR2, CYP7A1, CYP51A1 | TYR 3542/4885TRPV1 3970/4885SLC5A1 3035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.